Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03860558 · ClinicalTrials.gov registry record · NA

Impact of Metabolic Health on Sperm Epigenetic Marks in Humans

A NA study of Overweight and Type 2 Diabetes Mellitus, sponsored by Joslin Diabetes Center.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03860558 is a NA study of Overweight and Type 2 Diabetes Mellitus that is active but no longer recruiting, run by Joslin Diabetes Center. The registered enrollment target is 40 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03860558, a NA study of Overweight and Type 2 Diabetes Mellitus, is active but no longer recruiting, sponsored by Joslin Diabetes Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is designed to evaluate whether epigenetic markers in overweight men with type 1 diabetes (T1D) or type 2 diabetes (T2D) can be improved with a 3 month lifestyle intervention or program focused in glycemic intervention.

Conditions Studied

Overweight Type 2 Diabetes Mellitus Type 1 Diabetes Mellitus

Interventions

  • OTHER No Intervention
  • OTHER Lifestyle Intervention

Study Locations (1)

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-05-01
Est. Completion 2026-07-01
Phase NA

Sponsor

Joslin Diabetes Center

73 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03860558

The ClinicalTrials.gov registry entry for NCT03860558 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which No Intervention is the first listed.

NCT03860558 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03860558 about?

NCT03860558 is a clinical study titled "Impact of Metabolic Health on Sperm Epigenetic Marks in Humans". This study is designed to evaluate whether epigenetic markers in overweight men with type 1 diabetes (T1D) or type 2 diabetes (T2D) can be improved with a 3 month lifestyle intervention or program focused in glycemic intervention.

What is the current status of trial NCT03860558?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2018-05-01. Estimated completion is 2026-07-01.

What conditions does trial NCT03860558 study?

This clinical trial studies the following conditions: Overweight, Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus.

What interventions are being tested in trial NCT03860558?

The interventions under investigation include: No Intervention (OTHER), Lifestyle Intervention (OTHER).

Who is sponsoring clinical trial NCT03860558?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03860558 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Overweight

All registered trials for this condition

Type 2 Diabetes Mellitus

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.